Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

08/07/1988

Registered Address

Registered & Corporate Office : 717/718, Maker Chambers V, Nariman Point,
Mumbai, Maharashtra - 400021
Tel: 022-39267100, 62770477
Fax: 022-22833913

Registrar Office

Universal Capital Securities Pvt. Ltd.
21/25, Shakil Nivas,Opp. Satya Saibaba Temple,Mahakali Caves Road,
Mumbai,400093,Maharashtra
Tel: 022-28207203
Fax: 28262920

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal Ltd. - Announcement under Regulation 30 (LODR)-...

07-May-2021|11:32AM

Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 - Investo

Hikal Ltd. - Investor Presentation

07-May-2021|11:28AM

Hikal Limited has informed the Exchange about Investor Presentation

Hikal Ltd. - Announcement under Regulation 30 (LODR)-...

07-May-2021|11:27AM

Press Release under Regulation 30 of SEBI (LODR) Regulations 2015

Hikal Ltd. - Press Release

07-May-2021|11:26AM

Hikal Limited has informed the Exchange regarding a press release dated May

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug32.7076.47
Aarti Drug817.507,619.10
Abbott India16,110.0034,232.63
ABL Bio-Tech0.810.66
Add LifePhrm0.466.89
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
LIC MF ..2.680.79
Sundara..1.511.54
Sundara..1.220.64
Sundara..0.911.24
Sundara..0.890.66
More

Board Meetings

DatePurpose
06/05/2021Audited Results & F..
04/02/2021Quarterly Results &..
04/11/2020Quarterly Results
04/08/2020Quarterly Results
18/06/2020Audited Results & F..
More